Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
24.31
USD
|
+1.50%
|
|
+2.62%
|
+8.62%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,971
|
2,123
|
2,198
|
1,795
|
2,666
|
3,282
|
-
|
-
|
Enterprise Value (EV)
1 |
2,506
|
2,650
|
2,852
|
1,795
|
2,967
|
3,871
|
4,048
|
4,219
|
P/E ratio
|
42.1
x
|
26.1
x
|
30.9
x
|
-232
x
|
44.8
x
|
23.3
x
|
21.6
x
|
24.2
x
|
Yield
|
4.36%
|
4.51%
|
4.64%
|
5.92%
|
5%
|
4.77%
|
4.95%
|
5.29%
|
Capitalization / Revenue
|
12.1
x
|
11.9
x
|
11.4
x
|
9.15
x
|
12.2
x
|
13.5
x
|
12.3
x
|
12.3
x
|
EV / Revenue
|
15.3
x
|
14.9
x
|
14.8
x
|
9.15
x
|
13.6
x
|
15.9
x
|
15.2
x
|
15.9
x
|
EV / EBITDA
|
15.7
x
|
16.7
x
|
16.4
x
|
9.95
x
|
15.2
x
|
16.6
x
|
15.6
x
|
15.6
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
2.4
x
|
2.17
x
|
2.06
x
|
2.32
x
|
2.25
x
|
2.17
x
|
Nbr of stocks (in thousands)
|
95,557
|
95,736
|
96,297
|
96,605
|
119,112
|
134,993
|
-
|
-
|
Reference price
2 |
20.63
|
22.18
|
22.83
|
18.58
|
22.38
|
24.31
|
24.31
|
24.31
|
Announcement Date
|
2/20/20
|
2/10/21
|
2/16/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
163.4
|
178.3
|
192.4
|
196.1
|
217.8
|
243.9
|
266.6
|
265.8
|
EBITDA
1 |
159.5
|
158.6
|
174.1
|
180.3
|
195.6
|
233
|
258.9
|
269.9
|
EBIT
1 |
-
|
104.6
|
106.6
|
116.3
|
135.2
|
150
|
165
|
176.7
|
Operating Margin
|
-
|
58.64%
|
55.4%
|
59.29%
|
62.07%
|
61.5%
|
61.88%
|
66.47%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
71.98
|
-
|
-
|
113.8
|
120.1
|
124.1
|
Net income
1 |
46.36
|
80.87
|
71.98
|
-7.506
|
53.74
|
136.6
|
153.8
|
142.4
|
Net margin
|
28.37%
|
45.35%
|
37.42%
|
-3.83%
|
24.68%
|
56.02%
|
57.68%
|
53.56%
|
EPS
2 |
0.4900
|
0.8500
|
0.7400
|
-0.0800
|
0.5000
|
1.042
|
1.127
|
1.003
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.9000
|
1.000
|
1.060
|
1.100
|
1.120
|
1.160
|
1.202
|
1.285
|
Announcement Date
|
2/20/20
|
2/10/21
|
2/16/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
48.6
|
49.74
|
46.48
|
47.55
|
50.29
|
51.81
|
50.61
|
51.55
|
55.88
|
59.73
|
60.02
|
62.36
|
64.59
|
66.38
|
68
|
EBITDA
1 |
44.21
|
44.95
|
43.12
|
43.26
|
45.84
|
48.1
|
45.77
|
46.54
|
49.9
|
53.42
|
55.1
|
56.52
|
58.67
|
60.24
|
62.17
|
EBIT
1 |
-
|
23.84
|
25.82
|
28.67
|
28.38
|
33.41
|
31.46
|
-
|
-
|
37.72
|
36.05
|
37.61
|
38.07
|
38.26
|
40.26
|
Operating Margin
|
-
|
47.92%
|
55.55%
|
60.3%
|
56.43%
|
64.48%
|
62.17%
|
-
|
-
|
63.15%
|
60.05%
|
60.31%
|
58.94%
|
57.64%
|
59.2%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
27.51
|
28.88
|
28.76
|
28.68
|
29.29
|
Net income
1 |
11.92
|
18.26
|
-43.26
|
20.67
|
0.709
|
14.38
|
19.23
|
-0.484
|
8.696
|
26.3
|
32.53
|
33.89
|
34.6
|
35.61
|
37.14
|
Net margin
|
24.52%
|
36.72%
|
-93.09%
|
43.47%
|
1.41%
|
27.76%
|
37.99%
|
-0.94%
|
15.56%
|
44.02%
|
54.19%
|
54.35%
|
53.56%
|
53.64%
|
54.62%
|
EPS
2 |
0.1200
|
0.1800
|
-0.4500
|
0.2100
|
0.0100
|
0.1500
|
0.1900
|
-0.0100
|
0.0800
|
0.2200
|
0.2495
|
0.2596
|
0.2617
|
0.2689
|
0.2775
|
Dividend per Share
2 |
0.2650
|
0.2650
|
0.2750
|
0.2750
|
0.2750
|
0.2750
|
0.2800
|
0.2800
|
0.2800
|
0.2800
|
0.2900
|
0.2900
|
0.2900
|
0.2950
|
0.2983
|
Announcement Date
|
11/8/21
|
2/16/22
|
5/5/22
|
8/4/22
|
11/8/22
|
2/9/23
|
5/10/23
|
8/3/23
|
11/9/23
|
2/8/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
534
|
527
|
654
|
-
|
301
|
589
|
766
|
937
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.35
x
|
3.32
x
|
3.754
x
|
-
|
1.539
x
|
2.529
x
|
2.961
x
|
3.472
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
4.74%
|
9.15%
|
9.25%
|
9.15%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
5.31%
|
5.62%
|
5.28%
|
5.02%
|
Assets
1 |
-
|
-
|
-
|
-
|
1,012
|
2,430
|
2,912
|
2,837
|
Book Value Per Share
2 |
-
|
-
|
9.510
|
8.580
|
10.90
|
10.50
|
10.80
|
11.20
|
Cash Flow per Share
2 |
-
|
-
|
1.630
|
1.460
|
1.460
|
1.610
|
1.710
|
1.780
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/20/20
|
2/10/21
|
2/16/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Last Close Price
24.31
USD Average target price
25.25
USD Spread / Average Target +3.87% Consensus |
1st Jan change
|
Capi.
|
---|
| +8.62% | 3.28B | | +4.62% | 55.76B | | -11.72% | 17.72B | | -5.05% | 13.23B | | +1.40% | 7.68B | | -17.93% | 5.39B | | -2.31% | 3.23B | | -5.42% | 3.06B | | +12.61% | 2.73B | | -13.17% | 2.43B |
Healthcare REITs
|